Cancer incidence and mortality in China, 2022

Cancer has become a major public health problem in China, seriously affecting the health of Chinese residents, the national economy and the social development. Cancer registries can be used for continuous and dynamic monitoring of cancer incidence and mortality. Population-based cancer registries have been in operation in China for about 60 years.1 Cancer incidence, mortality and survival data provide scientific evidence to develop cancer prevention and control strategies, and to evaluate the effectiveness of the quality of medical and health work. China has already established a cancer surveillance system, and basically achieved a full coverage of all districts/counties. The cancer registration has greatly improved the cancer prevention and control in China. The National Cancer Center (NCC) is responsible for data collection and quality control, including the assessment of the validity, completeness and comparability of all cancer registry data based on the criteria of the “Guideline for Chinese Cancer Registration”2 and the criteria of the International Agency for Research on Cancer/International Association of Cancer Registries (IARC/IACR).3,4